• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Acadia Healthcare Company Inc. (Amendment)

    2/13/24 4:55:55 PM ET
    $ACHC
    Medical Specialities
    Health Care
    Get the next $ACHC alert in real time by email
    SC 13G/A 1 tv0168-acadiahealthcarecoinc.htm SCHEDULE 13G/A acadiahealthcarecoinc

    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Schedule 13G

    Under the Securities Exchange Act of 1934
    (Amendment No.: 8)*

    Name of issuer:  Acadia Healthcare Co Inc

    Title of Class of Securities:  Common Stock

    CUSIP Number:  00404A109

    Date of Event Which Requires Filing of this Statement: December 29, 2023

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☒ Rule 13d-1(b)

    ☐ Rule 13d-1(c)

    ☐ Rule 13d-1(d)

    *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

    (Continued on the following page(s))

     

     

    13G

    CUSIP No.:  00404A109

    1.  NAME OF REPORTING PERSON
    I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

    The Vanguard Group - 23-1945930

    2.  CHECK THE APPROPRIATE [LINE] IF A MEMBER OF A GROUP

    A. 

    B.  X

    3.  SEC USE ONLY

    4.  CITIZENSHIP OF PLACE OF ORGANIZATION

    Pennsylvania

    (For questions 5-8, report the number of shares beneficially owned by each reporting person with:)

    5.  SOLE VOTING POWER

    0

    6.  SHARED VOTING POWER

    31,453

    7.  SOLE DISPOSITIVE POWER

    8,733,284

    8.  SHARED DISPOSITIVE POWER

    128,143

    9.  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    8,861,427

    10.  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

    N/A

    11.  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

    9.61%

    12.  TYPE OF REPORTING PERSON

    IA

     

     

    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Schedule 13G
    Under the Securities Act of 1934

    Item 1(a) - Name of Issuer:

    Acadia Healthcare Co Inc

    Item 1(b) - Address of Issuer's Principal Executive Offices:

    6100 Tower Circle, Suite 1000
    Franklin, TN 37067

    Item 2(a) - Name of Person Filing:

    The Vanguard Group - 23-1945930

    Item 2(b) – Address of Principal Business Office or, if none, residence:

    100 Vanguard Blvd.
    Malvern, PA 19355

    Item 2(c) – Citizenship:

    Pennsylvania

    Item 2(d) - Title of Class of Securities:

    Common Stock

    Item 2(e) - CUSIP Number

    00404A109

    Item 3 - Type of Filing:

    This statement is being filed pursuant to Rule 13d-1.  An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E).

    Item 4 - Ownership:

      (a) Amount Beneficially Owned:

      (b) Percent of Class:

     

     

    (c)  Number of shares as to which such person has:

    (i)  sole power to vote or direct to vote:  

    (ii)  shared power to vote or direct to vote:  

    (iii)  sole power to dispose of or to direct the disposition of:  

    (iv)  shared power to dispose or to direct the disposition of:  

    Comments:

    The responses to questions 5 through 9 and 11 on the cover page(s) are incorporated by reference into this Item 4.  

    Item 5 - Ownership of Five Percent or Less of a Class:

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following ☐

    Item 6 - Ownership of More Than Five Percent on Behalf of Another Person:

    The Vanguard Group, Inc.'s clients, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities reported herein.

    No one other person's interest in the securities reported herein is more than 5%.

    Item 7 - Identification and Classification of the Subsidiary Which Acquired The Security Being Reported on by the Parent Holding Company:

    Not applicable

    Item 8 - Identification and Classification of Members of Group:

    Not applicable

    Item 9 - Notice of Dissolution of Group:

    Not applicable

    Item 10 - Certification:

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a-11.

    Signature

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Date:  February 13, 2024

    By /s/ Ashley Grim
    Name: Ashley Grim
    Title:  Head of Global Fund Administration

    Get the next $ACHC alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACHC

    DatePrice TargetRatingAnalyst
    8/14/2025$26.00Strong Buy → Outperform
    Raymond James
    2/28/2025$43.00 → $35.00Overweight → Equal Weight
    Barclays
    1/7/2025$70.00Sector Weight → Overweight
    KeyBanc Capital Markets
    12/12/2024$45.00 → $75.00Hold → Buy
    Deutsche Bank
    10/11/2024Sector Weight
    KeyBanc Capital Markets
    4/25/2024$70.00Sell → Hold
    Deutsche Bank
    3/6/2024$100.00Overweight
    Barclays
    4/21/2023$83.00Neutral
    Cantor Fitzgerald
    More analyst ratings

    $ACHC
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Acadia Healthcare Company Inc.

    SCHEDULE 13G/A - Acadia Healthcare Company, Inc. (0001520697) (Subject)

    8/12/25 10:34:26 AM ET
    $ACHC
    Medical Specialities
    Health Care

    SEC Form 10-Q filed by Acadia Healthcare Company Inc.

    10-Q - Acadia Healthcare Company, Inc. (0001520697) (Filer)

    8/5/25 4:45:57 PM ET
    $ACHC
    Medical Specialities
    Health Care

    Acadia Healthcare Company Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Acadia Healthcare Company, Inc. (0001520697) (Filer)

    8/5/25 4:33:19 PM ET
    $ACHC
    Medical Specialities
    Health Care

    $ACHC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, GC and Secretary Farley Brian covered exercise/tax liability with 1,095 shares, decreasing direct ownership by 2% to 71,080 units (SEC Form 4)

    4 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)

    7/29/25 5:01:04 PM ET
    $ACHC
    Medical Specialities
    Health Care

    Chief Financial Officer Dixon Heather Brianne covered exercise/tax liability with 2,410 shares, decreasing direct ownership by 2% to 118,581 units (SEC Form 4)

    4 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)

    7/29/25 5:01:06 PM ET
    $ACHC
    Medical Specialities
    Health Care

    Chief Executive Officer Hunter Christopher H. covered exercise/tax liability with 5,464 shares, decreasing direct ownership by 2% to 258,530 units (SEC Form 4)

    4 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)

    6/27/25 5:01:25 PM ET
    $ACHC
    Medical Specialities
    Health Care

    $ACHC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Acadia Healthcare Reports Second Quarter 2025 Results

    Provides Updated Guidance for 2025; Announces Chief Financial Officer Transition Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ:ACHC) today announced financial results for the second quarter ended June 30, 2025. Second Quarter 2025 Highlights Revenue totaled $869.2 million, an increase of 9.2% over the second quarter of 2024 Same facility revenue increased 9.5% compared with the second quarter of 2024, including an increase in revenue per patient day of 7.5% and an increase in patient days of 1.8% Net income attributable to Acadia totaled $30.1 million, or $0.33 per diluted share Adjusted income attributable to Acadia totaled $74.8 million, or $0.83 per

    8/5/25 4:05:00 PM ET
    $ACHC
    Medical Specialities
    Health Care

    Acadia Healthcare Announces Date for Second Quarter 2025 Earnings Release

    Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced that it will release its second quarter 2025 results on Tuesday, August 5, 2025, after the close of the market. Acadia will conduct a conference call with institutional investors and analysts at 9:00 a.m. ET on Wednesday, August 6, 2025. A live broadcast of the conference call will be available at www.acadiahealthcare.com in the "Investors" section of the website. The webcast of the conference call will be available for 30 days. About Acadia Healthcare Acadia is a leading provider of behavioral healthcare services across the United States. As of March 31, 2025, Acadia operated a network of 270 behavioral healthcare facilities

    7/18/25 11:00:00 AM ET
    $ACHC
    Medical Specialities
    Health Care

    Acadia Healthcare Reports First Quarter 2025 Results

    Affirms Full Year 2025 Guidance Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ:ACHC) today announced financial results for the first quarter ended March 31, 2025. First Quarter 2025 Highlights Revenue totaled $770.5 million, compared with $768.1 million for the first quarter of 2024 Same facility revenue increased 2.1% compared with the first quarter of 2024, including an increase in patient days of 2.2% Same facility revenue and patient day growth both included an unfavorable year-over-year impact from the leap year of approximately 1.1% Net income attributable to Acadia totaled $8.4 million, or $0.09 per diluted share Adjusted income attributable to Acadia

    5/12/25 4:07:00 PM ET
    $ACHC
    Medical Specialities
    Health Care

    $ACHC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Acadia Healthcare downgraded by Raymond James with a new price target

    Raymond James downgraded Acadia Healthcare from Strong Buy to Outperform and set a new price target of $26.00

    8/14/25 8:17:37 AM ET
    $ACHC
    Medical Specialities
    Health Care

    Acadia Healthcare downgraded by Barclays with a new price target

    Barclays downgraded Acadia Healthcare from Overweight to Equal Weight and set a new price target of $35.00 from $43.00 previously

    2/28/25 7:39:54 AM ET
    $ACHC
    Medical Specialities
    Health Care

    Acadia Healthcare upgraded by KeyBanc Capital Markets with a new price target

    KeyBanc Capital Markets upgraded Acadia Healthcare from Sector Weight to Overweight and set a new price target of $70.00

    1/7/25 7:39:01 AM ET
    $ACHC
    Medical Specialities
    Health Care

    $ACHC
    Leadership Updates

    Live Leadership Updates

    View All

    Agave Ridge Behavioral Hospital Hosts Ceremony to Celebrate Grand Opening

    Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced the opening of its newest acute care hospital, Agave Ridge Behavioral Hospital, located at 3322 S. Ellsworth Road, in Mesa, Arizona. A ribbon-cutting ceremony was held today to mark its grand opening. The first patient admissions are expected to follow in the coming days as the hospital completes its final preparations to provide care for those in need. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240411986178/en/Acadia Healthcare hosts ribbon-cutting ceremony on April 11, 2024, for its new behavioral health hospital in Mesa, Arizona. The new hospital, named Agave R

    4/11/24 2:16:00 PM ET
    $ACHC
    Medical Specialities
    Health Care

    Acadia Healthcare Appoints Dr. Stephanie Eken as Chief Medical Officer

    Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced the appointment of Dr. Stephanie Eken as the Company's new chief medical officer. Dr. Eken is a psychiatrist with more than two decades of experience across the spectrum of behavioral health. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240404108920/en/Acadia Healthcare Appoints Dr. Stephanie Eken as Chief Medical Officer (Photo: Business Wire) "Acadia is thrilled to welcome Dr. Eken as our new chief medical officer," said Chris Hunter, Chief Executive Officer of Acadia Healthcare. "Her experience and expertise will help Acadia set the standard for care across the i

    4/4/24 9:00:00 AM ET
    $ACHC
    Medical Specialities
    Health Care

    Henry Ford Health and Acadia Healthcare Appoint Emily Sexton as CEO of New Henry Ford Behavioral Health Hospital

    Henry Ford Health, one of the nation's premier academic and integrated health systems, and Acadia Healthcare, the nation's largest stand-alone behavioral healthcare company, today announced the appointment of Emily Sexton as Chief Executive Officer of Henry Ford Behavioral Health Hospital, the new 192-bed inpatient behavioral health hospital being built through a joint venture partnership between Henry Ford and Acadia in West Bloomfield, Michigan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240220715559/en/Henry Ford Health and Acadia Healthcare announced the appointment of Emily Sexton as Chief Executive Officer of Henry For

    2/20/24 1:00:00 PM ET
    $ACHC
    Medical Specialities
    Health Care

    $ACHC
    Financials

    Live finance-specific insights

    View All

    Acadia Healthcare Reports Second Quarter 2025 Results

    Provides Updated Guidance for 2025; Announces Chief Financial Officer Transition Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ:ACHC) today announced financial results for the second quarter ended June 30, 2025. Second Quarter 2025 Highlights Revenue totaled $869.2 million, an increase of 9.2% over the second quarter of 2024 Same facility revenue increased 9.5% compared with the second quarter of 2024, including an increase in revenue per patient day of 7.5% and an increase in patient days of 1.8% Net income attributable to Acadia totaled $30.1 million, or $0.33 per diluted share Adjusted income attributable to Acadia totaled $74.8 million, or $0.83 per

    8/5/25 4:05:00 PM ET
    $ACHC
    Medical Specialities
    Health Care

    Acadia Healthcare Announces Date for Second Quarter 2025 Earnings Release

    Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced that it will release its second quarter 2025 results on Tuesday, August 5, 2025, after the close of the market. Acadia will conduct a conference call with institutional investors and analysts at 9:00 a.m. ET on Wednesday, August 6, 2025. A live broadcast of the conference call will be available at www.acadiahealthcare.com in the "Investors" section of the website. The webcast of the conference call will be available for 30 days. About Acadia Healthcare Acadia is a leading provider of behavioral healthcare services across the United States. As of March 31, 2025, Acadia operated a network of 270 behavioral healthcare facilities

    7/18/25 11:00:00 AM ET
    $ACHC
    Medical Specialities
    Health Care

    Acadia Healthcare Reports First Quarter 2025 Results

    Affirms Full Year 2025 Guidance Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ:ACHC) today announced financial results for the first quarter ended March 31, 2025. First Quarter 2025 Highlights Revenue totaled $770.5 million, compared with $768.1 million for the first quarter of 2024 Same facility revenue increased 2.1% compared with the first quarter of 2024, including an increase in patient days of 2.2% Same facility revenue and patient day growth both included an unfavorable year-over-year impact from the leap year of approximately 1.1% Net income attributable to Acadia totaled $8.4 million, or $0.09 per diluted share Adjusted income attributable to Acadia

    5/12/25 4:07:00 PM ET
    $ACHC
    Medical Specialities
    Health Care

    $ACHC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Acadia Healthcare Company Inc.

    SC 13G/A - Acadia Healthcare Company, Inc. (0001520697) (Subject)

    11/14/24 1:28:32 PM ET
    $ACHC
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13G/A filed by Acadia Healthcare Company Inc.

    SC 13G/A - Acadia Healthcare Company, Inc. (0001520697) (Subject)

    11/12/24 9:50:14 AM ET
    $ACHC
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13G/A filed by Acadia Healthcare Company Inc.

    SC 13G/A - Acadia Healthcare Company, Inc. (0001520697) (Subject)

    11/8/24 10:52:39 AM ET
    $ACHC
    Medical Specialities
    Health Care